Back
Anheuser-Busch InBev NV Vs. Corcept Therapeutics, Inc. Industry Stock Comparison
Buy
61
BUD
Anheuser-Busch InBev NV
Last Price:
$64.61
Seasonality Move:
1.42%
Sell
36
CORT
Corcept Therapeutics, Inc.
Last Price:
$70.27
Seasonality Move:
6.8%
Buy
61
Anheuser-Busch InBev NV (BUD)
is a Buy
Is Anheuser-Busch InBev NV a Buy, Sell or Hold?
-
The current Anheuser-Busch InBev NV [BUD] share price is $64.61. The Score for BUD is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
BUD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Corcept Therapeutics, Inc. (CORT)
is a Sell
Is Corcept Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Corcept Therapeutics, Inc. [CORT] share price is $70.20. The Score for CORT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
CORT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BUD Stock Price Chart
What is Anheuser-Busch InBev NV's stock price today?
-
The Anheuser-Busch InBev NV share price today is $64.61Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BUD is experiencing buying pressure, which is a positive indicator for future bullish movement.
CORT Stock Price Chart
What is Corcept Therapeutics, Inc.'s stock price today?
-
The Corcept Therapeutics, Inc. share price today is $70.20Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CORT is experiencing selling pressure, which indicates risk of future bearish movement.
BUD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.64 | Buy |
| Relative Strength Index (14 RSI): | 59.77 | Buy |
| Chaikin Money Flow: | 563850 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.5 - 64.44) | Buy |
| Bollinger Bands (100): | (59.64 - 63.32) | Buy |
CORT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 32.16 | Sell |
| Chaikin Money Flow: | -2244663 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (78.7 - 85.94) | Sell |
| Bollinger Bands (100): | (71.38 - 83.18) | Sell |
BUD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.17 | Buy |
| 20-day SMA: | 63.19 | Buy |
| 50-day SMA: | 62.58 | Buy |
| 200-day SMA: | 63.93 | Buy |
| 8-day EMA: | 64.16 | Buy |
| 20-day EMA: | 63.55 | Buy |
| 50-day EMA: | 62.72 | Buy |
| 200-day EMA: | 62.27 | Buy |
CORT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 81.08 | Sell |
| 20-day SMA: | 83.06 | Sell |
| 50-day SMA: | 78.49 | Sell |
| 200-day SMA: | 74.04 | Sell |
| 8-day EMA: | 79.79 | Sell |
| 20-day EMA: | 81.21 | Sell |
| 50-day EMA: | 78.92 | Sell |
| 200-day EMA: | 51.36 | Buy |
Anheuser-Busch InBev NV Earnings Growth & BUD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.47 per share, and an increase next year of $0.69 per share.
Corcept Therapeutics, Inc. Earnings Growth & CORT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and an increase next year of $3.11 per share.
Anheuser-Busch InBev NV Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corcept Therapeutics, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||